Drug Shortage Report for ALLERJECT
| Report ID | 4027 |
| Drug Identification Number | 02382059 |
| Brand name | ALLERJECT |
| Common or Proper name | EPINEPHRINE SOLUTION FOR INJECTION, USP |
| Company Name | VALEO PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 0.15MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 UNITS/1 CARTON |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-03-23 |
| Actual start date | 2017-03-23 |
| Estimated end date | 2020-05-19 |
| Actual end date | 2020-05-19 |
| Shortage status | Resolved |
| Updated date | 2020-05-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16667 HYMUS BLVD. KIRKLAND, QUEBEC CANADA H9H 4R9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-05-29 | French | Compare |
| v4 | 2020-05-29 | English | Compare |
| v3 | 2017-03-24 | English | Compare |
| v2 | 2017-03-23 | French | Compare |
| v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5